Literature DB >> 24256522

What should be disclosed to research participants?

David Wendler1.   

Abstract

Debate surrounding the SUPPORT study highlights the absence of consensus regarding what information should be disclosed to potential research participants. Some commentators endorse the view that clinical research should be subject to high disclosure standards, even when it is testing standard-of-care interventions. Others argue that trials assessing standard-of-care interventions need to disclose only the information that is disclosed in the clinical care setting. To resolve this debate, it is important to identify the ethical concerns raised by clinical research and determine what consent process is needed to address them.

Entities:  

Mesh:

Year:  2013        PMID: 24256522      PMCID: PMC4154248          DOI: 10.1080/15265161.2013.851578

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  17 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Clinical trials in pediatric cancer: parental perspectives on informed consent.

Authors:  Mary Jo Kupst; Andrea Farkas Patenaude; Gary A Walco; Cheryl Sterling
Journal:  J Pediatr Hematol Oncol       Date:  2003-10       Impact factor: 1.289

Review 3.  Is volume related to outcome in health care? A systematic review and methodologic critique of the literature.

Authors:  Ethan A Halm; Clara Lee; Mark R Chassin
Journal:  Ann Intern Med       Date:  2002-09-17       Impact factor: 25.391

4.  Therapeutic misconception in clinical research: frequency and risk factors.

Authors:  Paul S Appelbaum; Charles W Lidz; Thomas Grisso
Journal:  IRB       Date:  2004 Mar-Apr

5.  Of mice but not men. Problems of the randomized clinical trial.

Authors:  S Hellman; D S Hellman
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

6.  The OHRP and SUPPORT.

Authors:  Benjamin S Wilfond; David Magnus; Armand H Antommaria; Paul Appelbaum; Judy Aschner; Keith J Barrington; Tom Beauchamp; Renee D Boss; Wylie Burke; Arthur L Caplan; Alexander M Capron; Mildred Cho; Ellen Wright Clayton; F Sessions Cole; Brian A Darlow; Douglas Diekema; Ruth R Faden; Chris Feudtner; Joseph J Fins; Norman C Fost; Joel Frader; D Micah Hester; Annie Janvier; Steven Joffe; Jeffrey Kahn; Nancy E Kass; Eric Kodish; John D Lantos; Laurence McCullough; Ross McKinney; William Meadow; P Pearl O'Rourke; Kathleen E Powderly; DeWayne M Pursley; Lainie Friedman Ross; Sadath Sayeed; Richard R Sharp; Jeremy Sugarman; William O Tarnow-Mordi; Holly Taylor; Tom Tomlinson; Robert D Truog; Yoram T Unguru; Kathryn L Weise; David Woodrum; Stuart Youngner
Journal:  N Engl J Med       Date:  2013-06-05       Impact factor: 91.245

7.  In support of SUPPORT--a view from the NIH.

Authors:  Kathy L Hudson; Alan E Guttmacher; Francis S Collins
Journal:  N Engl J Med       Date:  2013-06-05       Impact factor: 91.245

8.  The OHRP and SUPPORT--another view.

Authors:  Ruth Macklin; Lois Shepherd; Alice Dreger; Adrienne Asch; Francoise Baylis; Howard Brody; Larry R Churchill; Carl H Coleman; Ethan Cowan; Janet Dolgin; Jocelyn Downie; Rebecca Dresser; Carl Elliott; M Carmela Epright; Ellen K Feder; Leonard H Glantz; Michael A Grodin; William Hoffman; Barry Hoffmaster; David Hunter; Ana S Iltis; Jonathan D Kahn; Nancy M P King; Rory Kraft; Rebecca Kukla; Lewis Leavitt; Susan E Lederer; Trudo Lemmens; Hilde Lindemann; Mary Faith Marshall; Jon F Merz; Frances H Miller; Margaret E Mohrmann; Haavi Morreim; Meryl Nass; James L Nelson; John H Noble; Elizabeth Reis; Susan M Reverby; Anita Silvers; Aron C Sousa; Roy G Spece; Carson Strong; Judith P Swazey; Leigh Turner
Journal:  N Engl J Med       Date:  2013-06-26       Impact factor: 91.245

9.  The doctor as double agent.

Authors:  M Angell
Journal:  Kennedy Inst Ethics J       Date:  1993-09

Review 10.  Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.

Authors:  Jeffrey M Peppercorn; Jane C Weeks; E Francis Cook; Steven Joffe
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

View more
  9 in total

1.  Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers.

Authors:  Nut Koonrungsesomboon; Saranyapin Potikanond; Mingkwan Na Takuathung; Wutigri Nimlamool; Juntra Karbwang
Journal:  Eur J Clin Pharmacol       Date:  2019-08-19       Impact factor: 2.953

2.  Patients' Views Concerning Research on Medical Practices: Implications for Consent.

Authors:  Kevin P Weinfurt; Juli M Bollinger; Kathleen M Brelsford; Travis J Crayton; Rachel J Topazian; Nancy E Kass; Laura M Beskow; Jeremy Sugarman
Journal:  AJOB Empir Bioeth       Date:  2015-11-16

3.  A comparison of institutional review board professionals' and patients' views on consent for research on medical practices.

Authors:  Stephanie Alessi Kraft; Mildred K Cho; Melissa Constantine; Sandra Soo-Jin Lee; Maureen Kelley; Diane Korngiebel; Cyan James; Ellen Kuwana; Adrienne Meyer; Kathryn Porter; Douglas Diekema; Alexander M Capron; Radica Alicic; Benjamin S Wilfond; David Magnus
Journal:  Clin Trials       Date:  2016-06-01       Impact factor: 2.486

4.  Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial Protocol.

Authors:  Rachel Kohn; Anil Vachani; Dylan Small; Alisa J Stephens-Shields; Dorothy Sheu; Vanessa L Madden; Brian A Bayes; Marzana Chowdhury; Sadie Friday; Jannie Kim; Michael K Gould; Mohamed H Ismail; Beth Creekmur; Matthew A Facktor; Charlotte Collins; Kristina K Blessing; Christine M Neslund-Dudas; Michael J Simoff; Elizabeth R Alleman; Leonard H Epstein; Michael A Horst; Michael E Scott; Kevin G Volpp; Scott D Halpern; Joanna L Hart
Journal:  Ann Am Thorac Soc       Date:  2022-02

5.  Implications of the concept of minimal risk in research on informed choice in clinical practice.

Authors:  Kyoko Wada; Jeff Nisker
Journal:  J Med Ethics       Date:  2015-06-24       Impact factor: 2.903

6.  What information and the extent of information research participants need in informed consent forms: a multi-country survey.

Authors:  Juntra Karbwang; Nut Koonrungsesomboon; Cristina E Torres; Edlyn B Jimenez; Gurpreet Kaur; Roli Mathur; Eti N Sholikhah; Chandanie Wanigatunge; Chih-Shung Wong; Kwanchanok Yimtae; Murnilina Abdul Malek; Liyana Ahamad Fouzi; Aisyah Ali; Beng Z Chan; Madawa Chandratilake; Shoen C Chiew; Melvyn Y C Chin; Manori Gamage; Irene Gitek; Mohammad Hakimi; Narwani Hussin; Mohd F A Jamil; Pavithra Janarsan; Madarina Julia; Suman Kanungo; Panduka Karunanayake; Sattian Kollanthavelu; Kian K Kong; Bing-Ling Kueh; Ragini Kulkarni; Paul P Kumaran; Ranjith Kumarasiri; Wei H Lim; Xin J Lim; Fatihah Mahmud; Jacinto B V Mantaring; Siti M Md Ali; Nurain Mohd Noor; Kopalasuntharam Muhunthan; Elanngovan Nagandran; Maisarah Noor; Kim H Ooi; Jebananthy A Pradeepan; Ahmad H Sadewa; Nilakshi Samaranayake; Shalini Sri Ranganathan; Wasanthi Subasingha; Sivasangari Subramaniam; Nadirah Sulaiman; Ju F Tay; Leh H Teng; Mei M Tew; Thipaporn Tharavanij; Peter S K Tok; Jayanie Weeratna; Tri Wibawa; Renu Wickremasinghe; Phanthipha Wongwai; Subhash Yadav
Journal:  BMC Med Ethics       Date:  2018-09-15       Impact factor: 2.652

7.  Details of risk-benefit communication in informed consent documents for phase I/II trials.

Authors:  Hannes Kahrass; Sabine Bossert; Christopher Schürmann; Daniel Strech
Journal:  Clin Trials       Date:  2020-11-24       Impact factor: 2.486

Review 8.  Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.

Authors:  Cory E Goldstein; Charles Weijer; Jamie C Brehaut; Dean A Fergusson; Jeremy M Grimshaw; Austin R Horn; Monica Taljaard
Journal:  BMC Med Ethics       Date:  2018-02-27       Impact factor: 2.652

9.  Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease.

Authors:  Timothy Cardozo; Ronald Veazey
Journal:  Int J Clin Pract       Date:  2020-12-04       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.